dr. joyce o’shaughnessy on promising agents in triple-negative breast cancer
Published 8 years ago • 720 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:28
dr. o'shaughnessy on precision medicine in triple negative breast cancer
-
1:22
dr. o'shaughnessy on the utility of capivasertib in targeting akt in breast cancer
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
-
7:06
tnt study in triple negative breast cancer
-
1:51
dr. o'shaughnessy on breast cancer subtype-specific cytotoxic agents
-
5:58
other promising targets in tnbc
-
1:17
dr. o'shaughnessy on role of chemotherapy in future tnbc treatment
-
1:03
dr. o'shaughnessy on the future of tnbc treatment
-
1:44
dr. o'shaughnessy discusses negative tnbc iniparib trial results
-
12:47
neoadjuvant treatment in triple-negative breast cancer
-
1:40
dr. o'shaughnessy on the future of breast cancer biomarkers
-
1:47
dr. joyce o'shaughnessy on treatment with everolimus in advanced breast cancer
-
1:11
joyce o’shaughnessy, md: candidacy for eribulin therapy
-
41:55
headline news in breast cancer with dr. joyce o'shaughnessy
-
7:35
future directions for metastatic breast cancer
-
1:56
joyce o’shaughnessy, md: treatment goals for patients with tnbc and multiple metastatic sites
-
1:30
joyce o’shaughnessy, md, on the role of cdk4/6 inhibitors in the management of tnbc
-
0:53
joyce o’shaughnessy, md: principle third-line options for patients with metastatic tnbc
-
5:53
combining parp inhibitors checkpoint inhibitors in tnbc